Jul 30, 2021 (China Knowledge) - Jiangsu Gdk Biotechnology (688670) to start trading on the Shanghai Stock Exchange's STAR Market Aug 2, next Monday. The firm has issued 22.00 mln shares priced at RMB 55.18 per share raising RMB 1.21 bln. Its price-to-earnings ratio (PE) stands at 31.33. During subscription the IPO was 3,994 times oversubscribed.
CITIC Securities acts as the lead underwriter and sponsor for the IPO.
In FY 2020, Jiangsu Gdk Biotechnology garnered a total revenue of RMB 589.1 mln, up 777% YoY. In terms of net income, it achieved RMB 154.98 mln, rising 914% YoY. In Q1 2021, the company reported revenue of RMB 30.04 mln, a YoY decrease of 27%, and its net profits reached RMB -5.29 mln, down 227% YoY.
Copyright © 2018 www.chinaknowledge.com
Send feedback or comments to: firstname.lastname@example.org
For more news, financial weekly reports, business guides to China and other premium information, subscribe to China Knowledge today: www.chinaknowledge.com
To access our page on Bloomberg, type CKFI